Fig. 3From: Thymoquinone, piperine, and sorafenib combinations attenuate liver and breast cancers progression: epigenetic and molecular docking approachesAssessment of cell death mechanism in HepG2 after thymoquinone (TQ), piperine (PIP), and sorafenib (SOR) alone and combination treatments for 48 hs. Cells were double stained with annexin V-FITC and PI, analyzed by flow cytometry. Representative dot plots are shown (A). Percentage of live cells, necrotic cells and apoptotic (early + late) (B, C and D). Cell populations were plotted and represented collectively as percentage of total events. Data are expressed as the mean ± SEM; n = 3. Means within columns carrying * are significantly different at (p ˂0.05), ** (p ˂ 0.01), *** (p ˂ 0.001) and **** (p ˂ 0.0001)Back to article page